Diagnexia and Stratipath Partner to Expand AI-Based Cancer Precision Diagnostics Across the UK and Europe
1 April 2025
Diagnexia, and Stratipath AB are pleased to announce a strategic
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Diagnexia, and Stratipath AB are pleased to announce a strategic
Stratipath is proud to announce that globally recognized breast oncologist,
Stratipath has been recognized as one of the Gold Companies
Capio St Göranâs Hospital is one of the largest breast
SwAIPP 2, the continuation of the SwAIPP project, has been
Johan Hartman is a guest at the Johnson & Johnson
Diagnexia, and Stratipath AB are pleased to announce a strategic
Stratipath is proud to announce that globally recognized breast oncologist,
Capio St Göranâs Hospital is one of the largest breast
Stratipath has been recognized as one of the Gold Companies
SwAIPP 2, the continuation of the SwAIPP project, has been
Johan Hartman is a guest at the Johnson & Johnson